Evidence map›Paper›PMID 37978838›Full record

ArticleBioengineered2023

GXMR-CAR containing distinct GXM-specific single-chain variable fragment (scFv) mediated the cell activation against

Michele Procópio Machado, Matheus Henrique Dos Santos, Júlia Garcia Guimarães, Gabriela Yamazaki de Campos, Patrícia Kellen Martins Oliveira Brito, Camilly Melo Garcia Ferreira, Caroline Patini Rezende, Natália Fernandes Frota, Sandro Gomes Soares, Pappanaicken R Kumaresan and 2 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Bioengineered, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.7field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. State of the Field: Cytotoxic Immune Cell Responses inJournal of fungi (Basel, Switzerland) · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 3 countries.

Michele Procópio MachadoDepartment of Cellular and Molecular Biology, Ribeirao Preto Medical School, University of Sao Paulo, Ribeirao, Sao Paulo, Brazil.
Matheus Henrique Dos SantosDepartment of Cellular and Molecular Biology, Ribeirao Preto Medical School, University of Sao Paulo, Ribeirao, Sao Paulo, Brazil.
Júlia Garcia GuimarãesDepartment of Cellular and Molecular Biology, Ribeirao Preto Medical School, University of Sao Paulo, Ribeirao, Sao Paulo, Brazil.
Gabriela Yamazaki de CamposDepartment of Cellular and Molecular Biology, Ribeirao Preto Medical School, University of Sao Paulo, Ribeirao, Sao Paulo, Brazil.
Patrícia Kellen Martins Oliveira BritoDepartment of Cellular and Molecular Biology, Ribeirao Preto Medical School, University of Sao Paulo, Ribeirao, Sao Paulo, Brazil.
Camilly Melo Garcia FerreiraDepartment of Cellular and Molecular Biology, Ribeirao Preto Medical School, University of Sao Paulo, Ribeirao, Sao Paulo, Brazil.
Caroline Patini RezendeDepartment of Biochemistry and Immunology, Ribeirao Preto Medical School, University of Sao Paulo, Ribeirao, Sao Paulo, Brazil.
Natália Fernandes FrotaFederal University of Ceara (UFC), Fortaleza, Ceara, Brazil.
Sandro Gomes SoaresDepartment of Biochemistry, University of Cambridge, Cambridge, UK.
Pappanaicken R KumaresanDepartment of Hematopoietic Biology and Malignancy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Marcos Roberto LourenzoniFundação Oswaldo Cruz Ceará (Fiocruz-CE), Research Group on Protein Engineering and Health Solutions (GEPeSS), Eusébio, Ceara, Brazil.
Thiago Aparecido da SilvaDepartment of Cellular and Molecular Biology, Ribeirao Preto Medical School, University of Sao Paulo, Ribeirao, Sao Paulo, Brazil.ORCID 0000-0001-5017-6539
Universidade de São Paulo · BRFundação Oswaldo Cruz · BRThe University of Texas MD Anderson Cancer Center · USUniversidade Federal do Ceará · BRUniversity of Cambridge · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Cryptococcus neoformansReceptors, Chimeric AntigenSingle-Chain AntibodiesHumansInterleukin-2PolysaccharidesSignal TransductionInterleukin-2PolysaccharidesReceptors, Chimeric AntigenSingle-Chain AntibodiesChimeric antigen receptorcryptococcus sppGXMT cellstonic signaling

Identifiers

PMID37978838
PMCPMC10761124
OpenAlexW4388797275

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.